The Corporate Governance Report presents the structure, rules and processes that form the basis of Lonza’s corporate governance. The Report follows the structure of the SIX Swiss Exchange’s Directive on Information relating to Corporate Governance. The principles and rules of Lonza’s corporate governance are laid down in the Lonza Articles of Association and in the Regulations Governing Internal Organization and Board Committees, including their Charters. In the implementation of its corporate governance, Lonza follows the Swiss Code of Best Practice for Corporate Governance issued by the Swiss Business Federation economiesuisse.
As of 31 December 2025.
The Nomination and Governance Committee has been renamed People and Governance Committee, effective 1 January 2026.
Nationality: Dutch
Year of birth: 1969
Chair of the Board of Directors of Lonza Group Ltd (since May 2024), Independent member of the Board of Directors of Lonza Group Ltd (since May 2024).
Jean-Marc Huët was elected as Chair of the Board of Directors at the 2024 Annual General Meeting. Jean-Marc brings a strong international leadership track record, with current Chair roles at Heineken and Vermaat, among other senior responsibilities.
He has extensive international strategic leadership experience in the consumer, pharma and nutrition industries, having previously served as Chief Financial Officer of Unilever, Bristol-Myers Squibb and Royal Numico.
Jean-Marc Huët holds an MBA from INSEAD, Fontainbleau (FR).
Jean-Marc Huët is the Chair of the People and Governance Committee, which is responsible for overseeing governance, talent development, and succession planning for the Board and Executive Committee.
He is also a member of the Strategy and Innovation Committee, which is responsible for reviewing innovation and technology initiatives at Lonza, including ESG developments.
Nationality: German
Year of birth: 1958
Vice-Chair of the Board of Directors of Lonza Group Ltd (since August 2024); Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Jürgen Steinemann holds a degree in Economics and Business Management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).
Jürgen Steinemann is a member of the Remuneration Committee, which is responsible for reviewing and recommending compensation policies and plans, agreeing employment terms and evaluating the performance of the Executive Committee and the Chief Executive Officer.
He is also a member of the People and Governance Committee, which is responsible for overseeing governance, talent development, and succession planning for the Board and Executive Committee.
Nationality: Swiss
Year of birth: 1959
Lead Independent Director of the Board of Directors of Lonza Group Ltd (since November 2019); Independent member of the Board of Directors of Lonza Group Ltd (since April 2016).
Christoph Mäder holds a Master’s degree in law from the University of Basel (CH) and is admitted to the Swiss Bar.
Christoph Mäder is the Chair of the Remuneration Committee, which is responsible for reviewing and recommending compensation policies and plans, agreeing employment terms and evaluating the performance of the Executive Committee and the Chief Executive Officer.
He is also a member of the Audit and Compliance Committee, which is in charge of overseeing the systems of internal control and financial reporting, and compliance with laws and regulations, including the reporting and assurance process for ESG.
Nationality: Spanish
Year of birth: 1964
Independent member of the Board of Directors of Lonza Group Ltd (since May 2025).
Juan Andres has a career spanning more than 35 years during which he has held a variety of executive leadership positions. He was President, Strategic Partnerships and Enterprise Expansion at Moderna and led all manufacturing and technical development there during the COVID-19 pandemic. Prior to that, he led manufacturing worldwide and held other strategic roles at Novartis for 12 years, after spending more than 15 years at Eli Lilly. He has a deep strategic understanding of technical operations and quality that is complemented by international business expertise.
Juan holds a Master of Pharmacy from Alcala de Henares University (ES) and has completed the Accelerated Development Program at London Business School (UK).
Juan Andres is a member of the People and Governance Committee, which is responsible for overseeing governance, talent development, and succession planning for the Board and Executive Committee.
He is also a member of the Strategy and Innovation Committee, which is responsible for reviewing innovation and technology initiatives at Lonza, including ESG developments.
Nationality: French
Year of birth: 1961
Independent member of the Board of Directors of Lonza Group Ltd (since May 2025).
For more than 35 years, Eric Drapé has served in multiple leadership roles in the pharmaceutical industry at Teva Pharmaceuticals, Ipsen Pharma and Novo Nordisk. He has a wealth of international experience, having held positions in Denmark, France, Israel and the US.
Eric holds a Doctorate in Pharmacy and a DESS in Analytical Chemistry from Paris XI (FR). He also holds an Executive MBA from SIMI (now Copenhagen Business School) (DK).
Eric Drapé is a member of the Remuneration Committee, which is responsible for reviewing and recommending compensation policies and plans, agreeing employment terms and evaluating the performance of the Executive Committee and the Chief Executive Officer.
He is also a member of the Audit and Compliance Committee, which is in charge of overseeing the systems of internal control and financial reporting, and compliance with laws and regulations, including the reporting and assurance process for ESG.
Nationality: German
Year of birth: 1965
Independent member of the Board of Directors of Lonza Group Ltd (since May 2022).
Marion Helmes has extensive financial expertise as well as global operational experience from a career that includes Chief Financial Officer positions at Celesio, Q-Cells and with ThyssenKrupp’s Elevator and Stainless divisions. She currently holds Board Memberships with Siemens Healthineers AG and Heineken N.V.
Marion has a degree in Business Administration from Freie Universität Berlin and a PhD from the University of St. Gallen.
Marion Helmes is a member of the Audit and Compliance Committee, which is responsible for overseeing the systems of internal control and financial reporting, and compliance with laws and regulations, including the reporting and assurance process for ESG.
She is also a member of the People and Governance Committee, which is responsible for overseeing governance, talent development, and succession planning for the Board and Executive Committee.
Nationality: German, Brazilian
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).
Angelica Kohlmann holds a MD and doctorate in medicine from Hamburg University (DE).
Angelica Kohlmann is the Chair of the Strategy and Innovation Committee, which is responsible for reviewing innovation and technology initiatives at Lonza, including ESG developments.
She is also a member of the Remuneration Committee, which is responsible for reviewing and recommending compensation policies and plans, agreeing employment terms and evaluating the performance of the Executive Committee and the Chief Executive Officer.
Nationality: Swiss
Year of birth: 1957
Independent member of the Board of Directors of Lonza Group Ltd (since May 2025).
David has served as CFO of three publicly listed industrial and biotech companies and worked in various capital-intensive industries throughout his career. After serving as CFO and CAO of 3M Company as well as CFO of Amgen, one of the world’s largest independent biotech companies, David was CFO of Moderna during the COVID-19 pandemic. He has extensive governance, financial and industry experience, including business and IT services.
David holds a bachelor’s degree in Mechanical Engineering from Iowa State University (US), a master’s degree in Economics from London School of Economics (UK), and an MBA in Finance from the University of Chicago (US).
David Meline is a member of the Remuneration Committee, which is responsible for reviewing and recommending compensation policies and plans, agreeing employment terms and evaluating the performance of the Executive Committee and the Chief Executive Officer.
He is also a member of the Audit and Compliance Committee, which is in charge of overseeing the systems of internal control and financial reporting, and compliance with laws and regulations, including the reporting and assurance process for ESG.
Non-Executive Member of the Board, and Audit Committee, Eikon Therapeutics (since 2025)
Member of the Board, Member of the Finance, Investment and Technology Committee (since 2023), Chair of the Audit Committee (since 2024), HP Inc.
Non-Executive Member of the Board of Directors, and Chair of the Finance, Audit and Compliance Committee, ABB Ltd (since 2016)
Nationality: Swiss, German
Year of birth: 1961
Independent member of the Board of Directors of Lonza Group Ltd (since May 2022).
Roger Nitsch serves as CEO and President of Neurimmune, which he founded in 2006 with two business partners. A neuroscientist with a background in medicine, Roger is recognized as an opinion leader in neurodegenerative diseases with over 30 years of experience in Alzheimer’s disease research and drug development. A Potamkin Prize winner and Member of the German Academy of Sciences, Roger served as a founding director of the Institute for Regenerative Medicine (IREM), University of Zurich.
Roger Nitsch holds an MD degree from the University of Heidelberg and earned his post-doctoral qualification at the Massachusetts Institute of Technology and Harvard Medical School.
Roger Nitsch is a member of the Strategy and Innovation Committee, which is responsible for reviewing innovation and technology initiatives at Lonza, including ESG developments.
He is also a member of the People and Governance Committee, which is responsible for overseeing governance, talent development, and succession planning for the Board and Executive Committee.
Nationality: British
Year of birth: 1960
Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).
Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as CFO for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.
Barbara Richmond is the Chair of the Audit and Compliance Committee, which is responsible for overseeing the systems of internal control and financial reporting, and compliance with laws and regulations, including the reporting and assurance process for ESG.
Nationality: Belgian
Year of birth: 1972
Independent member of the Board of Directors of Lonza Group Ltd (from May 2018 until May 2025).
Olivier Verscheure holds a PhD in Computer Science from EPFL (July 1999).
Information tracked until the end of the mandate with Lonza Group Ltd.
Nationality: German
Year of birth: 1972
Chief Executive Officer (CEO) and Member of the Executive Committee (since July 2024).
Wolfgang holds a PhD in Organic and Bioorganic Chemistry from the University of Cologne (DE), as well as an Executive Master of Science in Finance from HEC Paris (FR).
Nationality: Swiss, German, French
Year of birth: 1972
Chief Financial Officer (CFO) and Member of the Executive Committee (since December 2021).
Philippe holds a master’s degree in Industrial Management and Manufacturing and a Bachelor’s Degree in Computer Science from the Swiss Federal Institute of Technology (ETH), Zurich (CH), as well as an MBA from Cornell University’s Johnson School (US).
Nationality: Spanish
Year of birth: 1969
Chief Quality Officer (since October 2025) and Member of the Executive Committee (since August 2022).
Maria Soler Nunez holds a PhD in Pharmacy in the area of Genetics, Molecular Biology from the Universidad Complutense de Madrid (ES).
Nationality: Romanian, Canadian, US, Swiss
Year of birth: 1971
Chief Human Resources Officer (CHRO) and Member of the Executive Committee (since November 2024).
Nicoleta holds a Master’s degree in Economics from the Academy of Economic Studies in Bucharest (RO).
Nationality: Swiss
Year of birth: 1968
Chief Legal & Corporate Affairs Officer and Member of the Executive Committee (since July 2025).
Andreas holds a Master of Laws (LLM) from New York University (US), a Habilitation in Law from the University of Zurich (CH) and is admitted as attorney-at-law in Zurich (CH).
Nationality: US
Year of birth: 1978
Jason holds a bachelor of science from the United States Military Academy (US) and MBA from University of Michigan (US).
Nationality: British
Year of birth: 1965
Head of Integrated Biologics (since April 2025) and Member of the Executive Committee (since April 2021)
Gordon Bates holds a master’s degree in Engineering Business Management from the University of Warwick (UK)
Nationality: German
Year of birth: 1975
Head of Advanced Synthesis (since April 2025) and Member of the Executive Committee (since July 2022).
Christian Seufert holds a master’s degree in Business Administration and Economics from the University of Hohenheim (DE).
Nationality: German, Italian, US
Year of birth: 1969
Head of Specialized Modalities (since April 2025) and Member of the Executive Committee (since November 2022)
Daniel Palmacci holds a master’s degree in Chemistry and Process Engineering with High Honors from the Technical University Berlin (DE).
Nationality: Swiss, French
Year of birth: 1972
Head of Capsules & Health Ingredients (since April 2025) and Member of the Executive Committee (since April 2021).
Jean-Christophe Hyvert holds a master’s degree in Physics from INSA, Rennes (FR) and an MBA from the Northwestern University (USA).
